Rawal RK - Search Results

1

Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits.

Banerjee A, Ganguly U, Saha S, Chakrabarti S, Saini RV, Rawal RK, Saso L, Chakrabarti S. Banerjee A, et al. Among authors: rawal rk. Expert Rev Anti Infect Ther. 2021 Oct;19(10):1245-1258. doi: 10.1080/14787210.2021.1905519. Epub 2021 Apr 1. Expert Rev Anti Infect Ther. 2021. PMID: 33739215 Free PMC article. Review.

2

COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?

Chakrabarti SS, Kaur U, Banerjee A, Ganguly U, Banerjee T, Saha S, Parashar G, Prasad S, Chakrabarti S, Mittal A, Agrawal BK, Rawal RK, Zhao RC, Gambhir IS, Khanna R, Shetty AK, Jin K, Chakrabarti S. Chakrabarti SS, et al. Among authors: rawal rk. Aging Dis. 2020 May 9;11(3):480-488. doi: 10.14336/AD.2020.0402. eCollection 2020 May. Aging Dis. 2020. PMID: 32489695 Free PMC article.

3

Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer's Disease.

Bhatia R, Chakrabarti SS, Kaur U, Parashar G, Banerjee A, Rawal RK. Bhatia R, et al. Among authors: rawal rk. Curr Alzheimer Res. 2021;18(10):802-830. doi: 10.2174/1567205018666211208140551. Curr Alzheimer Res. 2021. PMID: 34879800 Review.

4

Prospects of Treating Prostate Cancer through Apalutamide: A Mini-Review.

Singh R, Alsayadi YMMA, Singh VJ, Chawla PA, Rawal RK. Singh R, et al. Among authors: rawal rk. Anticancer Agents Med Chem. 2022;22(6):1056-1067. doi: 10.2174/1871520621666210824113736. Anticancer Agents Med Chem. 2022. PMID: 34431470 Review.

5

Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.

Bhatia R, Sharma A, Narang RK, Rawal RK. Bhatia R, et al. Among authors: rawal rk. Curr Mol Pharmacol. 2021;14(3):350-366. doi: 10.2174/1874467213666200730114943. Curr Mol Pharmacol. 2021. PMID: 32744982 Review.

6

Synthetic and Medicinal Perspective of Fused-Thiazoles as Anticancer Agents.

Pawar S, Kumar K, Gupta MK, Rawal RK. Pawar S, et al. Among authors: rawal rk. Anticancer Agents Med Chem. 2021;21(11):1379-1402. doi: 10.2174/1871520620666200728133017. Anticancer Agents Med Chem. 2021. PMID: 32723259 Review.

7

Exploring RdRp-remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV.

Singh PK, Pathania S, Rawal RK. Singh PK, et al. Among authors: rawal rk. SAR QSAR Environ Res. 2020 Nov;31(11):857-867. doi: 10.1080/1062936X.2020.1825014. SAR QSAR Environ Res. 2020. PMID: 33100032 Free PMC article.

8

RdRp (RNA-dependent RNA polymerase): A key target providing anti-virals for the management of various viral diseases.

Pathania S, Rawal RK, Singh PK. Pathania S, et al. Among authors: rawal rk. J Mol Struct. 2022 Feb 15;1250:131756. doi: 10.1016/j.molstruc.2021.131756. Epub 2021 Oct 17. J Mol Struct. 2022. PMID: 34690363 Free PMC article. Review.

9

Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma.

Kumar A, Bhatia R, Chawla P, Anghore D, Saini V, Rawal RK. Kumar A, et al. Among authors: rawal rk. Anticancer Agents Med Chem. 2020;20(10):1158-1172. doi: 10.2174/1871520620666200317105207. Anticancer Agents Med Chem. 2020. PMID: 32183683 Review.

10

Structure Based Drug Design: Clinically Relevant HIV-1 Integrase Inhibitors.

Kaur M, Rawal RK, Rath G, Goyal AK. Kaur M, et al. Among authors: rawal rk. Curr Top Med Chem. 2018;18(31):2664-2680. doi: 10.2174/1568026619666190119143239. Curr Top Med Chem. 2018. PMID: 30659539 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page